KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Debt to Equity (2016 - 2025)

Amgen (AMGN) has 17 years of Debt to Equity data on record, last reported at $6.31 in Q4 2025.

  • For Q4 2025, Debt to Equity fell 38.33% year-over-year to $6.31; the TTM value through Dec 2025 reached $6.31, down 38.33%, while the annual FY2025 figure was $6.31, 38.33% down from the prior year.
  • Debt to Equity reached $6.31 in Q4 2025 per AMGN's latest filing, up from $5.67 in the prior quarter.
  • Across five years, Debt to Equity topped out at $40.23 in Q1 2022 and bottomed at $3.5 in Q1 2021.
  • Average Debt to Equity over 5 years is $10.12, with a median of $9.0 recorded in 2025.
  • Peak YoY movement for Debt to Equity: skyrocketed 1048.97% in 2022, then tumbled 71.37% in 2023.
  • A 5-year view of Debt to Equity shows it stood at $4.97 in 2021, then skyrocketed by 113.98% to $10.64 in 2022, then fell by 2.54% to $10.37 in 2023, then dropped by 1.37% to $10.23 in 2024, then tumbled by 38.33% to $6.31 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt to Equity were $6.31 in Q4 2025, $5.67 in Q3 2025, and $7.57 in Q2 2025.